EGErfan Ghasemi

Erfan Ghasemi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erfan Ghasemi has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Webcam Use in Online Learning: A Cross-National Survey of Portuguese and Romanian University Students

    by Alexandre Duarte, Romina Surugiu, Mădălina Moraru, Irina Dinu, Erfan Ghasemi

    The landscape of digital pedagogy has undergone a profound transformation in recent years, a shift catalysed by the global disruptions of the COVID-19 pandemic. Central to this transition is the near-ubiquitous integration of webcams into the virtual classroom, a practice that has redefined traditional instructional spaces while broadening academic accessibility for a global student body. However, the rapid adoption of video-mediated learning has sparked ongoing debate regarding its pedagogical efficacy and ethical implications. This article investigates the multifaceted influence of webcam usage on the lived experiences of students, examining its impact on peer-to-peer social dynamics and the broader implications for learner well-being. The paper draws on a mixed-methods approach applied to a self-administered survey of 1,085 Portuguese and Romanian university students. This study shows that webcam use in online classes is shaped primarily by social and emotional factors rather than technological or academic ones. Students tend to keep their cameras off for comfort, privacy, and reduced social pressure. In contrast, camera use is mainly motivated by the desire to enhance interaction, attention, and respect for teachers. These findings highlight the need for flexible and inclusive webcam policies that balance social presence with students' well-being in digital learning environments.

  • Open Access

    Subgroups With Metabolic Syndrome Show Different Association With Ischemic Heart Disease and Stroke; Findings of Iran STEPS Survey 2021

    by Sogol Koolaji, Sina Azadnajafabad, Moein Yoosefi, Naser Ahmadi, Ali Golestani, Erfan Ghasemi, Arezou Dilmaghani‐Marand, Negar Rezaei, Ameneh Kazemi, Nazila Rezaei, et al.

    Background: Metabolic syndrome (MetS) is defined as clustering of 3 or more of 5 metabolic risk factors in an individual. It has been greatly using in clinical practice; although some research illustrated that it might not act as a homogenous disorder in association with cardiovascular diseases. Therefore, we aimed to investigate its prevalence and association with ischemic heart disease (IHD) and stroke. Methods: Using Iran STEPS (STEPwise Approach to NCD [Noncommunicable Diseases] Risk Factor Surveillance) Survey 2021, the prevalence and association of MetS, with prevalence of IHD and stroke was assessed. Given the definition of MetS, it includes 16 combinations (clusters) of 5 risk factors; we aggregated them into 6 groups and evaluated their association with prevalence of IHD and stroke. Results: Overall, 54.19% of total population had MetS, where the most prevalent criterion was elevated waist circumference. MetS was associated with 1.70 times greater adjusted odds ratio (OR) of IHD prevalence (95% CI, 1.40–2.07). A closer look reveals that the greatest OR of IHD prevalence was observed in individuals with all 5 risk factors or 4 risk factors including both elevated blood pressure and fasting plasma glucose with ORs of 6.69 (3.52–12.68) and 6.38 (3.38–12.03), respectively, compared with individuals with none of the risk factors (0 components). Conclusions: The association of MetS cluster with IHD and stroke prevalence varied. In addition to the dose–response relationship, the clusters characterized by both elevated BP and FPG are the most critical for targeting preventive and therapeutic measures.


  • Open Access

    Polypharmacy and Potentially Inappropriate Medication in Iranian People With Metabolic Syndrome: Epidemiological Aspects and Related Factors, a Multi‐Level Cross‐Sectional National Study

    by Mojdeh Daneshmand, Hamidreza Jamshidi, Mohammad‐Reza Malekpour, Erfan Ghasemi, Sahar Saeedi Moghaddam, Seyede Salehe Mortazavi, Mohsen Shati, Mohammad Hadi Farjoo, Farshad Farzadfar

    Background and Aims: Polypharmacy, characterized by the concurrent use of five or more medications in a prescription, potentially resulting in adverse outcomes, is frequently observed among individuals with metabolic syndrome, which encompasses a collection of conditions that co‐occur, heightening the likelihood of heart disease, stroke, and type 2 diabetes. This study seeks to ascertain the prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs) among Iranian patients with metabolic syndrome, while also evaluating the contributing individual and sociodemographic factors.Methods: This was a population‐based, cross‐sectional national study. Two databases were used: (a) Iranians Health Insurance Service database and (b) Iran's STEPS 2016 survey. Patients with metabolic syndrome conjoint in both databases were selected. Among these patients, polypharmacy and PIM were evaluated, and their association with individual and sociodemographic factors was assessed. Univariate and multivariate logistic regression were used to analyze the associations. All statistical analyses were done using SPSS 22 and Python 3.Results: Out of 2075 metabolic syndrome patients, 10.3% had polypharmacy. Polypharmacy significantly increased by age (OR: 4.334, adjusted for > 80‐year‐olds vs. 25–39‐year‐olds [CI: 1.664–11.283], p < 0.001), and its prevalence was significantly higher in urban areas (OR: 2.326 [CI: 1.645–3.288], p < 0.001). Polypharmacy was 5.88% in West, 5.41% in Southeast, 5.04% in Central, and 4.83% in North‐Northeast of Iran. PIM was 13.2% in ≥ 60 years and significantly higher in urban areas (OR: 2.014 [CI: 1.153–3.519], p < 0.001).Conclusions: Since the area of residency affects polypharmacy and PIM more significantly than wealth status and education level, it is important to implement preventive measures in urban areas.


  • Open Access

    Global and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990–2019

    by Shabnam Iezadi, Narges Ebrahimi, Seyyed-Hadi Ghamari, Zahra Esfahani, Negar Rezaei, Erfan Ghasemi, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Zhaleh Abdi, Zahra Shokri Varniab, et al.

    Background: The aim of this study was to examine the quality of care by age and gender in oesophageal cancer using Global Burden of Disease (GBD) database.Methods: Patients aged 20 and over with oesophageal cancer were included in this longitudinal study using GBD 1990–2019 data. We used the Socio-Demographic Index (SDI) to classify the regions. We used Principal Component Analysis (PCA) method to calculate the Quality of Care Index (QCI). The QCI was rescaled into a 0–100 single index, demonstrating that the higher the score, the better the QC.Results: The age-standardized QCI for oesophageal cancer dramatically increased from 23.5 in 1990 to 41.1 in 2019 for both sexes, globally. The high SDI regions showed higher QCI than the rest of the regions (45.1 in 1990 and 65.7 in 2019) whereas the low SDI regions had the lowest QCI, which showed a 4.5% decrease through the years (from 13.3 in 1990 to 12.7 in 2019). Globally, in 2019, the QCI showed the highest scores for patients aged 80–84, reported 48.2, and the lowest score for patients aged 25–29 reported 31.5, for both sexes. Globally, in 2019, age-standardized Gender Disparity Ratio (GDR) was 1.2, showing higher QCI in females than males.Conclusion: There were fundamental differences in the QCI both globally and regionally between different age groups as well as between males and females. To achieve the goal of providing high-quality services equally to people in need in all over the world, health systems need to invest in effective diagnostic services, treatments, facilities, and equipment and to plan for screening and surveillance of high-risk individuals.


  • Physical Inactivity, Inequalities, and Disparities Across Districts of Iran: A STEPs Survey-Based Analysis

    by Amirali Hajebi, Maryam Nasserinejad, Sina Azadnajafabad, Erfan Ghasemi, Negar Rezaei, Moein Yoosefi, Azin Ghamari, Mohammad Keykhaei, Ali Ghanbari, Esmaeil Mohammadi, et al.

    Background: We aimed to estimate the prevalence of physical inactivity in all districts of Iran and the disparities between subgroups defined by various measures. Methods: Small area estimation method was employed to estimate the prevalence of physical inactivity in districts based on the remaining districts in which data on the level of physical inactivity were available. Various comparisons on the estimations were done based on socioeconomic, sex, and geographical stratifications to determine the disparities of physical inactivity among districts of Iran. Results: All districts of Iran had a higher prevalence of physical inactivity compared with the world average. The estimated prevalence of physical inactivity among all men in all districts was 46.8% (95% uncertainty interval, 45.9%–47.7%). The highest and lowest estimated disparity ratio of physical inactivity were 1.95 and 1.14 in males, and 2.25 and 1.09 in females, respectively. Females significantly had a higher prevalence of 63.5% (62.7%–64.3%). Among both sexes, the poor population and urban residents significantly had higher prevalence of physical inactivity than rich population and rural residents, respectively. Conclusions: The high prevalence of physical inactivity among Iranian adult population suggests the urgent need to adopt population-wide action plans and policies to handle this major public health problem and avert the probable burden.


  • Top Cited Papers
    Open Access

    Protocol Design for Surveillance of Risk Factors of Non–communicable Diseases During the COVID-19 Pandemic: An Experience from Iran STEPS Survey 2021

    by Shirin Djalalinia, Sina Azadnajafabad, Erfan Ghasemi, Moein Yoosefi, Negar Rezaei, Yosef Farzi, Ameneh Kazemi, Naser Ahmadi, Maryam Nasserinejad, Nima Fattahi, et al.

    Background: Regarding the growing burden of non-communicable diseases (NCDs) and exposure to their risk factors, and the continuous need for nationwide data, we aimed to develop the latest round of the STEPwise Approach to NCD Risk Factor Surveillance (STEPS) survey in 2021 in Iran, while the COVID-19 pandemic was still present. Methods: In addition to the three main steps of this survey, including questionnaires, physical measurements, and laboratory assessments, we adapted the survey with the situation caused by the COVID-19 pandemic, by adding to various aspects of study phases and changing some scientific and executive procedures in this round of STEPS survey in Iran. These changes were beyond the initial novelties embedded within the survey before the pandemic, by refining the study protocol benefiting from the previous experiences of the STEPS survey. Results: By amending the required changes, we could include a total of 27874 individuals in the first step of the survey. This number was 27745 and 18119 for the second and third steps. Comparing the preliminary results with the previous nationwide surveys, this study was highly representative on both national and provincial levels. Also, implementing the COVID-19 prevention and control strategies in all stages of survey led to the least infection transmission between the study investigators and participants. Conclusion: The novel initiatives and developed strategies in this round of Iran STEPS survey provide a state-of-the-art protocol for national surveys in the presence of an overwhelming catastrophe like the COVID-19 pandemic and the triggered limitations and shortages of resources.


  • Open Access

    Optimization of Ventilation Therapy Prioritization Strategies among Patients with COVID-19: Lessons Learned from Real-World Data of nearly 600,000 Hospitalized Patients

    by Mohsen Abbasi-Kangevari, Ali Ghanbari, Mohammad-Reza Malekpour, Seyyed-Hadi Ghamari, Sina Azadnajafabad, Sahar Saeedi Moghaddam, Mohammad Keykhaei, Rosa Haghshenas, Ali Golestani, Mohammad-Mahdi Rashidi, et al.

    Summary: Objective: To investigate the benefit of ventilation therapy among various patient groups with COVID-19 admitted to hospitals, based on the real-world data of hospitalized adult patients. Methods: Data used in the longitudinal study included 599,340 records of hospitalized patients. All participants were categorized based on demographics and their date of hospitalization. Two models were used in this study: firstly, participants were assessed by their probability of receiving ventilation therapy during hospitalization using mixed-effects logistic regression. Secondly, the clinical benefit of receiving ventilation therapy among various patient groups was quantified while considering the probability of receiving ventilation therapy during hospital admission, as estimated in the first model. Findings: Among participants, 60,113 (10.0%) received ventilation therapy, 85,158 (14.2%) passed away due to COVID-19, and 514,182 (85.8%) recovered. Among all groups with sufficient data for analysis, patients aged 40-64 years who had chronic respiratory diseases (CRD) and malignancy benefitted the most from ventilation therapy; followed by patients aged 65+ years who had malignancy, cardiovascular diseases, and diabetes; and patients aged 18-39 years who had malignancy. Patients aged 65+ who had CRD and cardiovascular disease gained the least benefit from ventilation therapy. Conclusion: This study promotes a new aspect of treating patients for ventilators: it could be suggested that rather than focusing on the scarcity of ventilators, guidelines focus on decision-making algorithms to also take the usefulness of the intervention into account, whose beneficial effect is dependent on the selection of the right time in the right patient. Funding: This work was supported by the World Health Organization (WHO) Eastern Mediterranean Regional Office (EMRO) (Grant No. 202693061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Research in context: What was already known: Research has been ongoing to investigate the main principles for allocating scarce medical resources during pandemics. Medical experts working at the COVID-19 care units interact with patients of different socioeconomic, clinical, paraclinical, and overall health statuses. While physicians should not be faced with situations where they would be obliged to decide which patient to treat due to the risk of human error as well as the double-burden of life-long emotional toll, the pandemic has increased the likelihood of such dilemmas, especially in settings with limited resources. Serious discussions on the ethical considerations of ventilator allocation were also raised during the pandemic. Utility (maximizing benefits) and equity (distributive justice) were two concerns raised in decision making in such dilemma which has also been considered to be “the toughest triage”. What new knowledge the manuscript contributes: This longitudinal study provides new insights on optimizing the strategies for ventilation therapy prioritization among patients with COVID-19, based on the real-world data of nearly 600,000 hospitalized patients with COVID-19. So far, there has been focus on how to prioritize patients with COVID-19 for ventilation therapy. Nevertheless, there has not been much evidence on how much patients of different age groups with various underlying conditions actually benefitted from ventilation therapy based on real-world data. The results of this study could have a significant message: should the prioritization guidelines for ventilators allocation take no notice of the real-world data, patients might be deprived of ventilation therapy, who could benefit the most from it. This would pave the way to capture clearer picture in the possible future pandemics.

  • Open Access

    National and subnational burden of stroke in Iran from 1990 to 2019

    by Aida Fallahzadeh, Zahra Esfahani, Ali Sheikhy, Mohammad Keykhaei, Sahar Saeedi Moghaddam, Yeganeh Sharifnejad Tehrani, Negar Rezaei, Erfan Ghasemi, Sina Azadnajafabad, Esmaeil Mohammadi, et al.

    Background: Data on the burden of stroke and changing trends at national and subnational levels are necessary for policymakers to allocate recourses appropriately. This study presents estimates of the stroke burden from 1990 to 2019 using the results of the Global Burden of Disease (GBD) 2019 study.Methods: For the GBD 2019, verbal autopsy and vital registration data were used to estimate stroke mortality. Cause‐specific mortality served as the basis for estimating incidence, prevalence, and disability‐adjusted life years (DALYs). The burden attributable to stroke risk factors was calculated by a comparative risk assessment. Decomposition analysis was applied to determine the contribution of population aging, population growth, and changes in the age‐specific incidence rates.Results: In 2019, the number of prevalent cases, incident cases, and deaths due to stroke in Iran were 963,512; 102,778; and 40,912, respectively. The age‐standardized incidence rate (ASIR) and the age‐standardized death rate (ASDR) decreased from 1990 to 2019. Of national stroke ASDRs in 2019, 44.7% (35.7–54.7%) were attributable to hypertension and 28.8% (15.2–57.4) to high fasting plasma glucose. At the subnational level, the trend of the stroke incidence and mortality rate decreased in all provinces. Stroke was responsible for 4.48% of total DALYs in 2019 (3.38% due to ischemic stroke, 0.87% due to intracerebral hemorrhage, and 0.22% due to subarachnoid hemorrhage).Conclusion: ASIR and ASDR of stroke are decreasing nationally and subnationally; however, the number of incident cases and deaths are increasing in all SDI quintiles, possibly due to population growth.


  • Open Access

    COVID-19 in patients with diabetes: factors associated with worse outcomes

    by Negar Rezaei, Fateme Montazeri, Mohammad-Reza Malekpour, Ali Ghanbari, Sina Azadnajafabad, Esmaeil Mohammadi, Nazila Rezaei, Shohreh Naderimagham, Erfan Ghasemi, Mohsen Abbasi-Kangevari, et al.

    Purpose Diabetes is one of the major comorbidities associated with COVID-19. We aimed to determine the clinical and epidemiological factors associated with the mortality of COVID-19 in diabetic patients in Iran, and also the impact of prescribed antiviral and antibiotics on patients’ status. Methods In this study, we used the national registry of hospitalized patients with Severe Acute Respiratory Syndrome (SARS) Symptoms with diabetes from February 18, 2020, to December 22, 2020. Demographic, clinical features, treatments, concurrent comorbidities, and their associations with mortality and severity outcomes were assessed using logistic regression. Results 78,554 diabetic in-patients with SARS symptoms were included from 31 provinces of whom 37,338 were PCR positive for COVID-19. Older age and male gender are associated with COVID-19 mortality in diabetic patients. CVD is the most frequent comorbidity (42%). CVD, kidney disease, liver disease, and COPD are associated comorbidities which increased the risk of mortality. The mortality rate is higher in diabetic patients comparing to patients with no comorbidities, particularly in younger age groups. The frequency of antiviral, and antibiotics in COVID-19 positive patients was 34%, and 31%, respectively. Antibiotic treatment has no association with mortality in COVID-19 patients. Conclusions Diabetic patients indicate higher mortality comparing to patients without any underlying comorbidities. Restrict strategies on increasing effective health care utilization must be considered in diabetic patients, especially in those with parallel underlying comorbidities. Regarding the antibiotic resistance issue and the noticeable use of antibiotics in diabetic patients, it is recommended to prioritize an antibiotic guideline prescription in COVID-19 patients for better stewardship by countries.


  • Open Access

    Non-communicable Diseases’ Contribution to the COVID-19 Mortality: A Global Warning on the Emerging Syndemics

    by Sina Azadnajafabad, Erfan Ghasemi, Sahar Saeedi Moghaddam, Negar Rezaei, Farshad Farzadfar

    Non-communicable Diseases’ Contribution to the COVID-19 Mortality: A Global Warning on the Emerging Syndemics